Federated Hermes’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.6M | Sell |
43,585
-4,060
| -9% | -$783K | 0.01% | 683 |
|
|
2025
Q4 | $8.76M | Sell |
47,645
-11,362
| -19% | -$1.99M | 0.01% | 663 |
|
|
2025
Q3 | $9.05M | Sell |
59,007
-18,497
| -24% | -$2.8M | 0.02% | 588 |
|
|
2025
Q2 | $10.8M | Sell |
77,504
-20,559
| -21% | -$2.88M | 0.02% | 553 |
|
|
2025
Q1 | $14.4M | Sell |
98,063
-6,235
| -6% | -$902K | 0.03% | 473 |
|
|
2024
Q4 | $13.7M | Sell |
104,298
-26,264
| -20% | -$3.68M | 0.03% | 486 |
|
|
2024
Q3 | $20.3M | Sell |
130,562
-7,679
| -6% | -$1.24M | 0.04% | 418 |
|
|
2024
Q2 | $21.6M | Buy |
138,241
+3,284
| +2% | +$494K | 0.05% | 389 |
|
|
2024
Q1 | $18.3M | Sell |
134,957
-9,832
| -7% | -$1.3M | 0.04% | 434 |
|
|
2023
Q4 | $19.5M | Sell |
144,789
-3,639
| -2% | -$473K | 0.05% | 392 |
|
|
2023
Q3 | $20.1M | Buy |
148,428
+16
| +0% | +$2.19K | 0.05% | 366 |
|
|
2023
Q2 | $21.2M | Buy |
148,412
+242
| +0.2% | +$35.6K | 0.05% | 372 |
|
|
2023
Q1 | $20.6M | Sell |
148,170
-74,923
| -34% | -$10.1M | 0.05% | 385 |
|
|
2022
Q4 | $30.3M | Sell |
223,093
-20
| -0% | -$2.51K | 0.08% | 287 |
|
|
2022
Q3 | $24.5M | Buy |
223,113
+11,001
| +5% | +$1.4M | 0.07% | 331 |
|
|
2022
Q2 | $28M | Sell |
212,112
-121,870
| -36% | -$16M | 0.08% | 309 |
|
|
2022
Q1 | $44.3M | Sell |
333,982
-253,986
| -43% | -$30.5M | 0.1% | 254 |
|
|
2021
Q4 | $68.5M | Buy |
587,968
+138,810
| +31% | +$16.3M | 0.13% | 210 |
|
|
2021
Q3 | $54M | Buy |
449,158
+9,207
| +2% | +$1.07M | 0.1% | 254 |
|
|
2021
Q2 | $52.7M | Buy |
439,951
+113,082
| +35% | +$12.4M | 0.1% | 269 |
|
|
2021
Q1 | $32.5M | Buy |
326,869
+3,061
| +0.9% | +$308K | 0.06% | 376 |
|
|
2020
Q4 | $32.4M | Sell |
323,808
-30,911
| -9% | -$3.27M | 0.07% | 340 |
|
|
2020
Q3 | $38.9M | Sell |
354,719
-12,408
| -3% | -$1.38M | 0.09% | 257 |
|
|
2020
Q2 | $38.8M | Buy |
367,127
+5,094
| +1% | +$526K | 0.1% | 248 |
|
|
2020
Q1 | $32.3M | Buy |
362,033
+104,540
| +41% | +$9.84M | 0.1% | 233 |
|
|
2019
Q4 | $25.7M | Buy |
257,493
+116,510
| +83% | +$11M | 0.06% | 350 |
|
|
2019
Q3 | $12.6M | Sell |
140,983
-45,665
| -24% | -$3.96M | 0.03% | 493 |
|
|
2019
Q2 | $15.4M | Sell |
186,648
-27,689
| -13% | -$2.17M | 0.04% | 425 |
|
|
2019
Q1 | $17.3M | Sell |
214,337
-1,332,152
| -86% | -$105M | 0.04% | 381 |
|
|
2018
Q4 | $117M | Buy |
1,546,489
+324,808
| +27% | +$25.4M | 0.32% | 62 |
|
|
2018
Q3 | $96.7M | Sell |
1,221,681
-658,260
| -35% | -$49.8M | 0.23% | 95 |
|
|
2018
Q2 | $132M | Sell |
1,879,941
-249,922
| -12% | -$18M | 0.39% | 53 |
|
|
2018
Q1 | $149M | Sell |
2,129,863
-537,621
| -20% | -$37.2M | 0.43% | 47 |
|
|
2017
Q4 | $185M | Buy |
2,667,484
+856
| +0% | +$57.7K | 0.52% | 38 |
|
|
2017
Q3 | $181M | Buy |
2,666,628
+424,243
| +19% | +$26.8M | 0.52% | 37 |
|
|
2017
Q2 | $153M | Buy |
2,242,385
+78,128
| +4% | +$5.1M | 0.44% | 43 |
|
|
2017
Q1 | $135M | Buy |
2,164,257
+886,470
| +69% | +$51.6M | 0.38% | 47 |
|
|
2016
Q4 | $69.8M | Sell |
1,277,787
-683,158
| -35% | -$38.8M | 0.21% | 94 |
|
|
2016
Q3 | $129M | Buy |
1,960,945
+1,824,789
| +1,340% | +$119M | 0.37% | 48 |
|
|
2016
Q2 | $8.22M | Sell |
136,156
-58,554
| -30% | -$3.4M | 0.02% | 454 |
|
|
2016
Q1 | $11M | Buy |
194,710
+26,801
| +16% | +$1.61M | 0.03% | 404 |
|
|
2015
Q4 | $11.4M | Buy |
167,909
+18,886
| +13% | +$1.24M | 0.04% | 417 |
|
|
2015
Q3 | $9.48M | Buy |
149,023
+69,352
| +87% | +$4.56M | 0.03% | 446 |
|
|
2015
Q2 | $5.08M | Hold |
79,671
| – | – | 0.02% | 603 |
|
|
2015
Q1 | $5.45M | Buy |
79,671
+22,453
| +39% | +$1.56M | 0.02% | 581 |
|
|
2014
Q4 | $4.03M | Sell |
57,218
-161,103
| -74% | -$11.5M | 0.01% | 697 |
|
|
2014
Q3 | $15.6M | Buy |
218,321
+198,321
| +992% | +$14.5M | 0.05% | 338 |
|
|
2014
Q2 | $1.49M | Sell |
20,000
-3,818,900
| -99% | -$276M | ﹤0.01% | 1053 |
|
|
2014
Q1 | $249M | Sell |
3,838,900
-261,948
| -6% | -$16.9M | 0.83% | 19 |
|
|
2013
Q4 | $243M | Buy |
4,100,848
+83,471
| +2% | +$4.53M | 0.84% | 20 |
|
|
2013
Q3 | $209M | Buy |
4,017,377
+328,954
| +9% | +$16.5M | 0.8% | 22 |
|
|
2013
Q2 | $174M | Buy |
+3,688,423
| New | +$188M | 0.69% | 29 |
|
Other funds holding AZN
IA
VCM
VAM
Federated Hermes's AZN Position: Q1 2026 in Review
Federated Hermes reduced its AstraZeneca (AZN) stake by 8.5% in Q1 2026, selling an estimated $783K and leaving 43,585 shares worth $8.6M. The position accounts for 0.01% of the portfolio, ranked #683.
Federated Hermes first reported a position in AZN in Q2 2013 and has held it in 52 quarters since. The position peaked at $249M in Q1 2014. 1,379 funds tracked by Wall St. Rank hold AZN as of Q1 2026.
- Federated Hermes held 43,585 shares of AstraZeneca worth $8.6M as of Q1 2026.
- Federated Hermes sold 4,060 AstraZeneca shares in Q1 2026, an estimated $783K.
- AstraZeneca made up 0.01% of Federated Hermes's portfolio in Q1 2026, its #683 holding.
- Federated Hermes first reported a position in AstraZeneca in Q2 2013 and has held it in 52 quarters since.
- Federated Hermes's AstraZeneca position peaked at $249M in Q1 2014.
- 1,379 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.
Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.